₩22,750.00 ($16.95)

+600.00 (+2.71%)

Weekly Expected Move ±5.4%

₩20300 ₩21525 ₩22750 ₩23975 ₩25200

KOE · Healthcare · Medical - Pharmaceuticals · Tech Score Buy · Power 61 · ₩1.03T mcap · 25M float · 1.81% daily turnover

Revenue

$926.9B +14.1% ▲

5Y CAGR: +10.6%

Gross Profit

$501.6B +12.0% ▲

5Y CAGR: +8.5%

Operating Income

$96.5B +20.0% ▲

5Y CAGR: +2.6%

Net Income

$66.0B +7.8% ▲

5Y CAGR: +3.4%

EPS (Diluted)

$1475.00 +7.9% ▲

5Y CAGR: +3.4%

EBITDA

$128.0B +11.3% ▲

5Y CAGR: +5.8%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$594.2B	$661.6B	$731.0B	$812.2B	$926.9B
YoY Growth	+6.3%	+11.4%	+10.5%	+11.1%	+14.1%
Cost of Revenue	$248.2B	$286.5B	$326.0B	$364.3B	$425.3B
Gross Profit	$346.0B	$375.2B	$405.0B	$447.9B	$501.6B
Gross Margin	58.2%	56.7%	55.4%	55.1%	54.1%
R&D Expenses	$24.7B	$21.8B	$25.5B	$30.3B	$32.8B
SG&A Expenses	$256.9B	$207.7B	$311.2B	$250.9B	$405.1B
Operating Expenses	$282.8B	$302.9B	$338.2B	$367.5B	$405.1B
Operating Income	$63.2B	$73.9B	$66.9B	$80.4B	$96.5B
Operating Margin	10.6%	11.2%	9.1%	9.9%	10.4%
Interest Expense	$2.9B	$4.3B	$5.9B	$4.5B	$18.6B
Income Before Tax	$69.8B	$68.6B	$60.8B	$84.7B	$92.6B
Tax Expense	$16.8B	$13.9B	$12.0B	$22.4B	$18.7B
Net Income	$50.3B	$52.9B	$47.2B	$61.2B	$66.0B
Net Margin	8.5%	8.0%	6.5%	7.5%	7.1%
EPS (Diluted)	$1125.82	$1182.73	$1054.64	$1367.34	$1475.00
EBITDA	$89.0B	$91.0B	$88.7B	$115.0B	$128.0B
Shares Outstanding	45M	45M	45M	45M	45M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$200.9B	$210.9B	$223.7B	$233.5B	$226.8B	$242.9B	$251.0B	$258.9B
Cost of Revenue	$89.4B	$97.2B	$103.8B	$109.1B	$102.4B	$110.0B	$112.7B	$117.7B
Gross Profit	$111.4B	$113.8B	$119.9B	$124.4B	$124.4B	$132.9B	$138.3B	$141.1B
Gross Margin	55.5%	53.9%	53.6%	53.3%	54.9%	54.7%	55.1%	54.5%
R&D Expenses	$7.5B	$7.5B	$7.7B	$8.0B	$8.3B	$8.8B	$9.5B	$8.7B
SG&A Expenses	$61.2B	$65.5B	$84.5B	$102.3B	$67.1B	$75.1B	$77.0B	$106.4B
Operating Expenses	$86.7B	$96.1B	$94.6B	$102.3B	$99.6B	$108.6B	$111.0B	$115.1B
Operating Income	$22.5B	$17.7B	$25.3B	$22.1B	$24.8B	$24.2B	$27.3B	$26.1B
Operating Margin	11.2%	8.4%	11.3%	9.5%	10.9%	10.0%	10.9%	10.1%
Interest Expense	$863M	$706M	$610M	$576M	$479M	$17.0B	$333M	$679M
Income Before Tax	$26.6B	$15.5B	$22.7B	$23.3B	$28.8B	$17.8B	$30.2B	$23.3B
Tax Expense	$5.4B	$7.2B	$4.7B	$5.2B	$6.5B	$2.2B	$3.9B	$6.1B
Net Income	$19.3B	$8.6B	$16.5B	$15.8B	$20.0B	$13.9B	$24.9B	$17.5B
Net Margin	9.6%	4.1%	7.4%	6.8%	8.8%	5.7%	9.9%	6.8%
EPS (Diluted)	$431.00	$192.76	$369.00	$353.14	$446.00	$308.91	$553.06	$389.03
EBITDA	$29.5B	$24.0B	$32.8B	$30.0B	$32.8B	$32.3B	$35.6B	$34.9B
Shares Outstanding	45M	44M	45M	45M	45M	45M	45M	45M

086450.KQ KOE